Discordant disability data in multiple sclerosis phase 3 studies among sphingosine-1- receptor modulator drugs

Research output: Contribution to journal › Comment/debate

Original language	English
Article number	102529
Journal	Multiple Sclerosis and Related Disorders
Volume	46
DOIs	https://doi.org/10.1016/j.msard.2020.102529
State	Published - Nov 2020

ASJC Scopus subject areas

TY - JOUR

T1 - Discordant disability data in multiple sclerosis phase 3 studies among sphingosine-1- receptor modulator drugs

AU - Avasarala, Jagannadha

PY - 2020/11

Y1 - 2020/11

UR - http://www.scopus.com/inward/record.url?scp=85091661244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85091661244&partnerID=8YFLogxK

U2 - 10.1016/j.msard.2020.102529

DO - 10.1016/j.msard.2020.102529

M3 - Comment/debate

C2 - 33010583

AN - SCOPUS:85091661244

SN - 2211-0348

VL - 46

JO - Multiple Sclerosis and Related Disorders

JF - Multiple Sclerosis and Related Disorders

M1 - 102529

ER -